PROGRAM

The 2nd Congress of the Macedonian Hematology Association with International Participation
18 April 2017 (Tuesday)
Time		Lecture	Lecturer
09:00-09:30	Opening of the Congress
SESSION 1: Updates on acute leukemia's and myelodisplastic syndromes
Chairs: Lidija Cevreska, Hagop Kantarjian
Time
09:30-11:35
09:30-10:05	Lecture 1	Recent advances in AML	Farhad Ravandi-Kashani, USA
10:05-10:40	Lecture 2	Recent advances in MDS	Elias Jabbour, USA
10:40-11:15	Lecture 3	Recent advances in ALL	Hagop M. Kantarjian, USA
11:15-11:35	Coffee break
SESSION 2: Updates on myeloproliferative disorders
Chairs: Irina Panovska, Ellias Jabbour
Time
11:35-13:20
11:35-12:10	Lecture 1	Recent advances in CML	Elias Jabbour, USA
12:10-12:45	Lecture 2	Molecular Diagnostics and Pathogenesis of Myeloproliferative Neoplasms (MPNs)	Sylvie Heurmouet, France
12:45-13:20	Lecture 3	Recent advances in the Classification and treatment of myeloproliferative neoplasms (MPNs)	Mary Francys McMulin, Ireland
13:20-14:20	Lunch break
SESSION 3: Updates in laboratory hematology
Chairs: Ivanovski Martin, Oliver Karanfilski
Time
14:20-15:20
14:20-14:50	Lecture 1	Flagship and hardship: minimal residual disease detection by flow cytometry	Janos Kappelmayer, Hungary
14:50-15:20	Lecture 2	A novel, digital image-based system for Complete Blood Count and WBC Differential counting	Milenko Tanasijevic, USA
SESSION 4: Updates on myeloma and lymphoma
Chairs: Urban Novak, Aleksandar Stojanovik
Time
15:20-17:40
15:20-15:55	Lecture 1	Indolent lymphomas: curative or palliative approach?	Urban Novak, Switzerland
15:55-16:30	Lecture 2	Recent advances in treatment of Hodgkin's lymphoma	Igor Aurer, Croatia
16:30-17:05	Lecture 3	Aggressive lymphomas: the WHO classification update and its clinical consequences	Urban Novak, Switzerland
17:05-17:40	Lecture 4	The immune checkpoint network in the bone marrow of myeloma patients: lessons from Vgamma9Vdelta2 T cells	Massimo Massaia, Italy
17:40-18:00	Coffee break
SESSION 5 Workshop: Updates on CLL
Chairs: Efremov Dimitar, Kostas Stamatopoulos
Time
18:00-19:45
18:00-18:35	Lecture 1	Prognostication in CLL: the art of synthesis	Kostas Stamatopoulos, Greece
18:35-19:10	Lecture 2	Current therapeutic options in CLL	Luca Laurenti, Italy
19:10-19:45	Lecture 3	Novel targeted therapies in CLL: mechanisms of action and resistance	Dimitar Efremov, Italy
20:00-21:30		OPENING CEREMONY/COCKTAIL
19 April (Wednesday ) 2017
Time		Lecture	Lecturer
SESSION 6: Insights in non-malignant hematological disorders
Chairs: Stankovic Svetlana, Dimovski Aleksandar
Time
08:45-10:05
08:45-09:05	Lecture 1	Cancer-associated thrombosis: prevention and treatment	Darko Antic, Serbia
09:05-09:25	Lecture 2	Inborn thrombophilia	Sasko Petlickovski, Macedonia
09:25-09:45	Lecture 3	Beta Thalassemia Intermedia: from Genotype to Phenotype	Dijana Plaseska-Karanfilska, Macedonia
09:45-10:05	Coffee break
10:05-11:05	Novo Noridsk symposium: Life threatening bleeding disorders in haemophilia with inhibitors
SESSION 7: Insights in Bone marrow transplant
Chairs: Nadezda basara , Aleskandra Pivkova-Veljanovska
Time
11:05-12:00
11:05-11:35	Lecture 1	How to prevent relapse after allogeneic stem cell transplantation in acute myeloid leukemia's?	Nadezda Basara, Germany
11:35-11:55	Lecture 2	Chronic GVHD and current treatment options	Mutlu Arat, Turkey
11:55-12:20	Lecture 3	Bone marrow transplantation experience of University Hospital of Hematology - Sofia Bulgaria	Gjorgji Mihajlov, Bulgaria
12:20-13:20	Roche symposium: Improving treatment strategies for FL patients: how to translate novel study data into clinical practice
13:20-14:00	Lunch break
SESSION 8: Insights in MDS and lymphoma
Chairs: Trajkova Sanja, Marek Trneny
Time
14:00-15:30
14:00-14:20	Lecture 1	Myelodysplastic syndromes landscapes and their modifying	Rajko Kusec, Croatia
14:20-14:40	Lecture 2	Recent advances in treatment of Mantle cell lymphoma	Marek Trneny, Czech Republic
14:40-15:10	Lecture 3	The role of prognostic scores in folicular lymphoma in Rituximab era	Biljana Mihaljevic, Serbia
15:10-15:30	Lecture 4	Histological and immunohistochemical study of Malignant Lymphomas in Macedonia: study of 222 cases.	Gordana Petrusevska, Macedonia
15:30-16:30	Novartis Myelofibrosis symposium
16:30-17:30	Coffee break + poster session (Chairs: Tatjana Smilevska, Gabriela Kostova, Svetlana Kocheva)
SESSION 9:
Chairs: Stojanovski Zlate, Sonja Genadieva-Stavric
Time
17:30-18:00
17:30-17:40	poster 1	Treatment and clinical results in childhood acute myeloid leukemia in Macedonia	Kocheva Svetlana, Macedonia
17:40-17:50	poster 2	Elderly patients with AML our treatment experience	Biljana Todorova et all.,Slovenia
17:50-18:00	poster 3	Position paper of the Association of Hematologists and Transfusiologists of Federation of Bosnia and Herzegovina on the use of biosimilars	Azra Jahic et all, Bosnia and Herzegovina
18:00-18:10	poster 4	Unclassified Case, probably Peripheral T Cell Lymphoma of cerebellum	Janevska Vesna, Macedonia
19:00-20:15	Commercial presentation: Gazyva engineered for superiority
20:30-24:00	Gala dinner
20 April 2017 (THURSDAY)
Time		Lecture	Lecturer
09:30-10:30		Celgene-sponsored satellite symposium: Azacitidine in the treatment of MDS and AML
SESSION 10:Workshop about PET SCEN
Chairs: Emilija Janevik-Ivanovska, Raffaele Giubbini
Time
10:30-12:15
10:30-11:05	Lecture 1	“PET/CT in myeloma”	Jean-Noel Talbot, France
11:05-11:35	Lecture 2	PET/CT in the management of Lymphomas"	Raffaele Giubbini,Italy
11:35-12:10	Lecture 3	Role of radiopharmaceuticals in the diagnosis and treatment of hematological diseases”	Emilija Janevik-Ivanovska, Macedonia
12:10-12:30	Coffee break
12:30-13:30	PLIVA/TEVA symposium: Lonquex (lipegfilgrastim): new option for chemotherapy-induced neutropenia
13:30-14:30	Lunch break
SESSION 11: pediatric session
Chairs: Martinova Kata, Janez Jazbec
Time
14:30-16:00
14:30-14:50	Lecture 1	Acute Lymphoblastic leukemia in childhood- Prognostic factors	Kata Martinova, Macedonia
14:50-15:10	Lecture 2	Late effects of the treatment for childhood cancer	Jelena Roganovic, Croatia
15:10-15:30	Lecture 3	Relapsed pediatric acute lymphoblastic leukemia-current strategies and perspectives	Janez Jazbec, Slovenia
15:30-15:50	Lecture 4	The influence of TSER(2R/3R) and (G2677T/A) polymorphisms on methotrexate induced toxicities in children with acute lymphoblastic leukemia	Biljana Coneska-Jovanova, Macedonia
16:00	Closing of the Congress